Elevance Net Debt from 2010 to 2024

ELV Stock

USD 407.60 5.05 1.25%

Elevance Health Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt will likely drop to about 9.6 B in 2024. Net Debt is the total debt of Elevance Health minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2001-09-30

Previous Quarter

21.2 B

Current Value

19.3 B

Quarterly Volatility

5.8 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Elevance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevance Health's main balance sheet or income statement drivers, such as Interest Expense of 1.1 B, Total Revenue of 179.9 B or Gross Profit of 56 B, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0153 or PTB Ratio of 1.5. Elevance financial statements analysis is a perfect complement when working with Elevance Health Valuation or Volatility modules.

Check out the analysis of Elevance Health Correlation against competitors.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Latest Elevance Health's Net Debt Growth Pattern

Below is the plot of the Net Debt of Elevance Health over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Elevance Health's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevance Health's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Elevance Net Debt Regression Statistics

	Arithmetic Mean	13,051,685,795
	Geometric Mean	10,553,702,783
	Coefficient Of Variation	35.42
	Mean Deviation	3,180,188,485
	Median	13,751,000,000
	Standard Deviation	4,622,474,253
	Sample Variance	21367268.2T
	Range	18.3B
	R-Value	0.63
	Mean Square Error	13786400.4T
	R-Squared	0.40
	Significance	0.01
	Slope	654,431,459
	Total Sum of Squares	299141755.1T

Elevance Net Debt History

	2024	9.6 B
	2023	18.6 B
	2022	16.7 B
	2021	18.2 B
	2020	14.3 B
	2019	15.1 B
	2018	15.3 B

Other Fundumenentals of Elevance Health

Net Debt To E B I T D A

Elevance Health Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Intangible Assets	Property Plant Equipment	Net Receivables	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock
Total Assets		0.99	0.93	0.84	0.81	0.58	0.98	0.98	0.9	0.76	0.78	0.75	0.6	0.09	0.77	0.98	0.43	0.2	0.94	-0.7	0.59	0.0	0.67	0.68	-0.58
Total Stockholder Equity	0.99		0.92	0.84	0.8	0.59	0.96	0.97	0.94	0.74	0.78	0.71	0.61	0.23	0.82	0.98	0.44	0.15	0.91	-0.69	0.53	-0.04	0.61	0.63	-0.52
Net Debt	0.93	0.92		0.73	0.68	0.56	0.97	0.87	0.89	0.6	0.84	0.62	0.64	0.19	0.74	0.95	0.59	0.01	0.82	-0.7	0.39	0.13	0.42	0.45	-0.38
Total Liab	0.84	0.84	0.73		0.98	0.8	0.82	0.81	0.81	0.96	0.66	0.95	0.49	0.04	0.84	0.87	0.43	0.33	0.9	-0.85	0.82	0.02	0.69	0.83	-0.77
Retained Earnings	0.81	0.8	0.68	0.98		0.79	0.78	0.77	0.73	0.99	0.65	0.96	0.52	-0.04	0.76	0.82	0.32	0.47	0.91	-0.82	0.85	-0.02	0.73	0.88	-0.8
Accounts Payable	0.58	0.59	0.56	0.8	0.79		0.6	0.56	0.57	0.79	0.5	0.79	0.29	0.03	0.7	0.64	0.47	0.33	0.67	-0.79	0.62	0.05	0.43	0.64	-0.56
Long Term Debt	0.98	0.96	0.97	0.82	0.78	0.6		0.93	0.89	0.72	0.82	0.74	0.6	0.1	0.76	0.98	0.53	0.16	0.9	-0.73	0.51	0.08	0.59	0.59	-0.5
Short Term Investments	0.98	0.97	0.87	0.81	0.77	0.56	0.93		0.89	0.73	0.68	0.7	0.5	0.08	0.77	0.94	0.4	0.17	0.93	-0.63	0.59	-0.03	0.7	0.69	-0.6
Intangible Assets	0.9	0.94	0.89	0.81	0.73	0.57	0.89	0.89		0.65	0.71	0.63	0.51	0.43	0.91	0.95	0.58	-0.13	0.79	-0.7	0.44	0.04	0.41	0.47	-0.41
Property Plant Equipment	0.76	0.74	0.6	0.96	0.99	0.79	0.72	0.73	0.65		0.56	0.97	0.43	-0.13	0.71	0.76	0.28	0.53	0.88	-0.76	0.89	-0.03	0.78	0.93	-0.84
Net Receivables	0.78	0.78	0.84	0.66	0.65	0.5	0.82	0.68	0.71	0.56		0.59	0.79	0.18	0.65	0.81	0.42	0.09	0.71	-0.76	0.33	0.16	0.36	0.38	-0.3
Total Current Assets	0.75	0.71	0.62	0.95	0.96	0.79	0.74	0.7	0.63	0.97	0.59		0.39	-0.19	0.69	0.75	0.42	0.51	0.85	-0.79	0.86	0.0	0.76	0.89	-0.82
Short Term Debt	0.6	0.61	0.64	0.49	0.52	0.29	0.6	0.5	0.51	0.43	0.79	0.39		0.09	0.35	0.6	0.01	0.15	0.6	-0.48	0.34	-0.2	0.24	0.34	-0.31
Common Stock	0.09	0.23	0.19	0.04	-0.04	0.03	0.1	0.08	0.43	-0.13	0.18	-0.19	0.09		0.48	0.21	0.22	-0.56	-0.08	-0.13	-0.44	0.0	-0.39	-0.4	0.5
Current Deferred Revenue	0.77	0.82	0.74	0.84	0.76	0.7	0.76	0.77	0.91	0.71	0.65	0.69	0.35	0.48		0.84	0.57	-0.11	0.72	-0.82	0.46	0.17	0.4	0.48	-0.41
Good Will	0.98	0.98	0.95	0.87	0.82	0.64	0.98	0.94	0.95	0.76	0.81	0.75	0.6	0.21	0.84		0.54	0.11	0.91	-0.76	0.54	0.04	0.56	0.61	-0.52
Deferred Long Term Liab	0.43	0.44	0.59	0.43	0.32	0.47	0.53	0.4	0.58	0.28	0.42	0.42	0.01	0.22	0.57	0.54		-0.14	0.26	-0.41	0.14	0.13	0.05	0.11	-0.12
Net Tangible Assets	0.2	0.15	0.01	0.33	0.47	0.33	0.16	0.17	-0.13	0.53	0.09	0.51	0.15	-0.56	-0.11	0.11	-0.14		0.35	-0.11	0.52	-0.33	0.57	0.64	-0.49
Long Term Debt Total	0.94	0.91	0.82	0.9	0.91	0.67	0.9	0.93	0.79	0.88	0.71	0.85	0.6	-0.08	0.72	0.91	0.26	0.35		-0.74	0.76	0.0	0.8	0.84	-0.75
Capital Surpluse	-0.7	-0.69	-0.7	-0.85	-0.82	-0.79	-0.73	-0.63	-0.7	-0.76	-0.76	-0.79	-0.48	-0.13	-0.82	-0.76	-0.41	-0.11	-0.74		-0.56	-0.35	-0.42	-0.54	0.5
Long Term Investments	0.59	0.53	0.39	0.82	0.85	0.62	0.51	0.59	0.44	0.89	0.33	0.86	0.34	-0.44	0.46	0.54	0.14	0.52	0.76	-0.56		-0.06	0.76	0.95	-0.99
Short Long Term Debt	0.0	-0.04	0.13	0.02	-0.02	0.05	0.08	-0.03	0.04	-0.03	0.16	0.0	-0.2	0.0	0.17	0.04	0.13	-0.33	0.0	-0.35	-0.06		-0.11	-0.11	0.07
Cash And Equivalents	0.67	0.61	0.42	0.69	0.73	0.43	0.59	0.7	0.41	0.78	0.36	0.76	0.24	-0.39	0.4	0.56	0.05	0.57	0.8	-0.42	0.76	-0.11		0.89	-0.79
Net Invested Capital	0.68	0.63	0.45	0.83	0.88	0.64	0.59	0.69	0.47	0.93	0.38	0.89	0.34	-0.4	0.48	0.61	0.11	0.64	0.84	-0.54	0.95	-0.11	0.89		-0.95
Capital Stock	-0.58	-0.52	-0.38	-0.77	-0.8	-0.56	-0.5	-0.6	-0.41	-0.84	-0.3	-0.82	-0.31	0.5	-0.41	-0.52	-0.12	-0.49	-0.75	0.5	-0.99	0.07	-0.79	-0.95

Click cells to compare fundamentals

About Elevance Health Financial Statements

Elevance Health investors use historical fundamental indicators, such as Elevance Health's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevance Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	18.6 B	9.6 B
Net Debt To EBITDA	1.77	1.22

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Elevance Net Debt from 2010 to 2024

Latest Elevance Health's Net Debt Growth Pattern

Elevance Net Debt Regression Statistics

Elevance Net Debt History

Other Fundumenentals of Elevance Health

Elevance Health Net Debt component correlations

About Elevance Health Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Elevance Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY